International Stem Cell Corporation (OTCBB:ISCO) develops a powerful new stem cell technology called “parthenogenesis” that pr..
| Home | My Account | Directories |
PRWEB: Absorption Systems Expands In Vivo Drug and Medical Device Testing Capabilities
Published on 2012-02-01 10:18:00
Preclinical contract research organization renovates facility, adding state-of-the-art technology and upgrading ocular testing services.Exton, PA (PRWEB) January 31, 2012Absorption Systems announces the latest in a series of milestones in the continuing expansion of its AAALAC-accredited and GLP-compliant facility in San Diego, CA. The facility is undergoing extensive renovations to upgrade and expand the company’s in vivo testing capabilities for drugs and medical devices, including the
International Stem Cell Corporation - "How Is Parthenogenesis Done?"
Published on 2011-12-29 10:40:00
San Diego Research Ethics ConsortiumSalk Institute for Biological StudiesParthenogenetic stem cell lines: Ethical considerationsInternational Stem Cell’s Director of Research and Therapeutic Development, Nikolay Turovets, PhD, presents “How is Parthenogenesis Done?”How is Parthenogenesis Done? (ANIMATED)
RegBlog: Over-Regulation of Parthenotes Stifles Valuable Scientific Research - by Sean J. Kealy
Published on 2011-12-16 10:38:00
A recent article in Scientific American questioned whether research on stem cell lines derived from unfertilized eggs was too tightly regulated by the federal government. Now that technology allows the creation of stem cells without fertilization, there is no question that federal laws and guidelines are overly restrictive, causing a detrimental effect on valuable scientific inquiry. Since 1996, Congress has included the Dickey-Wicker Amendment in the an